149 related articles for article (PubMed ID: 2927968)
21. [New aspects in the diagnosis and therapy of fetal lung immaturity. Determination of the infant respiratory system compliance. Analysis of dipalmitoylphosphatidylcholine in amniotic fluid. Use of carnitine for the enhancement of lung maturation. (Clinical and experimental results)].
Salzer H
Wien Klin Wochenschr Suppl; 1982; 136():1-30. PubMed ID: 6761979
[TBL] [Abstract][Full Text] [Related]
22. Determination of the pulmonary surfactant-associated protein SP-B in amniotic fluid with a competition ELISA.
Dilger I; Schwedler G; Dudenhausen JW
Gynecol Obstet Invest; 1994; 38(1):24-7. PubMed ID: 7959321
[TBL] [Abstract][Full Text] [Related]
23. Relation of amniotic fluid lecithin/sphingomyelin ratio and fetal asphyxia to respiratory distress syndrome in premature infants.
Worthington D; Smith BT
Can Med Assoc J; 1978 Jun; 118(11):1384-9. PubMed ID: 657031
[TBL] [Abstract][Full Text] [Related]
24. A new method for measurement of surfactant specific apoprotein in amniotic fluid.
Kashiwabara Y; Onoyama Y; Shimokawa H; Hisanaga S; Nakano H
Int J Gynaecol Obstet; 1989 Jun; 29(2):147-52. PubMed ID: 2568290
[TBL] [Abstract][Full Text] [Related]
25. Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies.
Delgado JC; Greene MF; Winkelman JW; Tanasijevic MJ
Am J Clin Pathol; 2000 Feb; 113(2):233-9. PubMed ID: 10664625
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary surfactant protein A in sera for assessing neonatal lung maturation.
Kaneko K; Shimizu H; Arakawa H; Ogawa Y
Early Hum Dev; 2001 Apr; 62(1):11-21. PubMed ID: 11245991
[TBL] [Abstract][Full Text] [Related]
27. Relationships among human amniotic fluid dipalmitoyl lecithin, postpartum respiratory compliance, and neonatal respiratory distress syndrome.
Lohninger A; Salzer H; Simbruner G; Husslein P; Martin G
Clin Chem; 1983 Apr; 29(4):650-5. PubMed ID: 6687565
[TBL] [Abstract][Full Text] [Related]
28. Amniotic fluid absorbance at 650 nm: a comparison with fetal lung maturity characteristics.
Khouzami VA; Beck JC; Johnson JW; Mitzner W; London WT
Am J Obstet Gynecol; 1981 Sep; 141(2):212-6. PubMed ID: 6912764
[TBL] [Abstract][Full Text] [Related]
29. Deficient lung surfactant apoproteins in amniotic fluid with mature phospholipid profile from diabetic pregnancies.
Katyal SL; Amenta JS; Singh G; Silverman JA
Am J Obstet Gynecol; 1984 Jan; 148(1):48-53. PubMed ID: 6546325
[TBL] [Abstract][Full Text] [Related]
30. Use of the drop volume of amniotic fluid in estimating the risk for respiratory distress syndrome in the newborn infant.
Aberg A; Gislen L
Am J Obstet Gynecol; 1986 Jan; 154(1):68-74. PubMed ID: 3753823
[TBL] [Abstract][Full Text] [Related]
31. Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay.
Kaplan LA; Chapman JF; Bock JL; Santa Maria E; Clejan S; Huddleston DJ; Reed RG; Bernstein LH; Gillen-Goldstein J
Clin Chim Acta; 2002 Dec; 326(1-2):61-8. PubMed ID: 12417097
[TBL] [Abstract][Full Text] [Related]
32. The amniotic fluid foam test, L/S ratio, and total phospholipids in the evaluation of fetal lung maturity.
Caspi E; Schreyer P; Tamir I
Am J Obstet Gynecol; 1975 Jun; 122(3):323-6. PubMed ID: 1173324
[TBL] [Abstract][Full Text] [Related]
33. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
Hallman M; Merritt TA; Akino T; Bry K
Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of dipalmitoyl-phosphatidyl-choline (DPPC) in amniotic fluid: a new sensitive method for surfactant determination].
Salzer H
Wien Klin Wochenschr; 1982 Dec; 94(24):673-6. PubMed ID: 6897802
[TBL] [Abstract][Full Text] [Related]
35. Comparison of amniotic fluid disaturated phosphatidylcholine, phosphatidylglycerol and lecithin/sphingomyelin ratio in predicting the risk of developing neonatal respiratory distress syndrome.
Higuchi M; Hirano H; Gotoh K; Otomo K; Maki M
Gynecol Obstet Invest; 1990; 29(2):92-6. PubMed ID: 2335315
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary surfactant and amniotic fluid lipids.
Biezenski JJ
Obstet Gynecol Annu; 1976; 5():71-102. PubMed ID: 824585
[No Abstract] [Full Text] [Related]
37. Surfactant protein A in the course of respiratory distress syndrome.
Stevens PA; Schadow B; Bartholain S; Segerer H; Obladen M
Eur J Pediatr; 1992 Aug; 151(8):596-600. PubMed ID: 1505580
[TBL] [Abstract][Full Text] [Related]
38. Amniotic fluid shake test versus lecithin-sphingomyelin ratio in the antenatal prediction of respiratory distress syndrome.
Szabó IM; Csaba IF; Drozgyik IA; Novák PF
Z Geburtshilfe Perinatol; 1977 Aug; 181(4):260-3. PubMed ID: 578601
[TBL] [Abstract][Full Text] [Related]
39. Assessment of surfactant activity in amniotic fluid for evaluation of fetal lung maturity.
Shelley SA; Takagi LR; Balis JU
Am J Obstet Gynecol; 1973 Jun; 116(3):369-76. PubMed ID: 4707539
[No Abstract] [Full Text] [Related]
40. [Fetal pulmonary maturity, II. Diagnosis].
Massobrio M; Ansaldi E; Chiappa A
Ric Clin Lab; 1980; 10 Suppl 1():135-48. PubMed ID: 7008162
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
